M0CRPC overview of management options
Sign Up to like & getrecommendations! Published in 2019 at "World Journal of Urology"
DOI: 10.1007/s00345-019-02997-z
Abstract: Though prostate cancer usually responds to androgen deprivation therapy (ADT) in the beginning, the majority of prostate cancers will develop castration resistance over time. The androgen receptor (AR) pathway is often found to be activated… read more here.
Keywords: m0crpc overview; management options; urology; castration ... See more keywords